Defining the Interaction of HIV-1 with the Mucosal Barriers of the Female Reproductive Tract

ABSTRACT Worldwide, HIV-1 infects millions of people annually, the majority of whom are women. To establish infection in the female reproductive tract (FRT), HIV-1 in male ejaculate must overcome numerous innate and adaptive immune factors, traverse the genital epithelium, and establish infection in underlying CD4+ target cells. How the virus achieves this remains poorly defined. By utilizing a new technique, we define how HIV-1 interacts with different tissues of the FRT using human cervical explants and in vivo exposure in the rhesus macaque vaginal transmission model. Despite previous claims of the squamous epithelium being an efficient barrier to virus entry, we reveal that HIV-1 can penetrate both intact columnar and squamous epithelial barriers to depths where the virus can encounter potential target cells. In the squamous epithelium, we identify virus entry occurring through diffusive percolation, penetrating areas where cell junctions are absent. In the columnar epithelium, we illustrate that virus does not transverse barriers as well as previously thought due to mucus impediment. We also show a statistically significant correlation between the viral load of inocula and the ability of HIV-1 to pervade the squamous barrier. Overall, our results suggest a diffusive percolation mechanism for the initial events of HIV-1 entry. With these data, we also mathematically extrapolate the number of HIV-1 particles that penetrate the mucosa per coital act, providing a biological description of the mechanism for HIV-1 transmission during the acute and chronic stages of infection.

[1]  Gianguido C. Cianci,et al.  Human cervicovaginal mucus contains an activity that hinders HIV-1 movement , 2012, Mucosal Immunology.

[2]  T. Hope,et al.  Expression of Structural Proteins in Human Female and Male Genital Epithelia and Implications for Sexually Transmitted Infections1 , 2012, Biology of reproduction.

[3]  W. Greene,et al.  Differential Transmission of HIV Traversing Fetal Oral/Intestinal Epithelia and Adult Oral Epithelia , 2011, Journal of Virology.

[4]  M. McElrath,et al.  Vaginal Langerhans Cells Nonproductively Transporting HIV-1 Mediate Infection of T Cells , 2011, Journal of Virology.

[5]  Sa Azin,et al.  An overview on the 2008 UNAIDS Report on the 2008 UNAIDS Report on the Global AIDS Epidemic. , 2010 .

[6]  D. Schust,et al.  Caveats associated with the use of human cervical tissue for HIV and microbicide research. , 2010, AIDS.

[7]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[8]  Christopher D Pilcher,et al.  Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection , 2007, AIDS.

[9]  T. Hope,et al.  Activated CD34-Derived Langerhans Cells Mediate Transinfection with Human Immunodeficiency Virus , 2007, Journal of Virology.

[10]  Y. Kooyk,et al.  Langerin is a natural barrier to HIV-1 transmission by Langerhans cells , 2007, Nature Medicine.

[11]  M. McElrath,et al.  Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1 , 2007, Immunity.

[12]  R. Veazey,et al.  Distribution of simian immunodeficiency virus target cells in vaginal tissues of normal rhesus macaques: implications for virus transmission. , 2006, Journal of reproductive immunology.

[13]  A. Quayle,et al.  Immunological Microenvironments in the Human Vagina and Cervix: Mediators of Cellular Immunity Are Concentrated in the Cervical Transformation Zone1 , 2005, Biology of reproduction.

[14]  P. Cossart,et al.  Microbial strategies to target, cross or disrupt epithelia. , 2005, Current opinion in cell biology.

[15]  T. Schacker,et al.  HIV binding, penetration, and primary infection in human cervicovaginal tissue. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Marc C. Johnson,et al.  The stoichiometry of Gag protein in HIV-1 , 2004, Nature Structural &Molecular Biology.

[17]  John P. Moore,et al.  Inhibiting sexual transmission of HIV-1 infection , 2003, Nature Reviews Microbiology.

[18]  D. McDonald,et al.  Recruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions , 2003, Science.

[19]  Pranab K Sen,et al.  Estimating correlation by using a general linear mixed model: evaluation of the relationship between the concentration of HIV‐1 RNA in blood and semen , 2003, Statistics in medicine.

[20]  Patrick J. Heagerty Analysis of Longitudinal Data , 2003 .

[21]  P. Reichelderfer,et al.  Recent observations on HIV type-1 infection in the genital tract of men and women. , 2003, AIDS.

[22]  D. McDonald,et al.  Visualization of the intracellular behavior of HIV in living cells , 2002, The Journal of cell biology.

[23]  George H. Patterson,et al.  A Photoactivatable GFP for Selective Photolabeling of Proteins and Cells , 2002, Science.

[24]  R. Brookmeyer,et al.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda , 2001, The Lancet.

[25]  S. Mboup,et al.  High Levels of Tumor Necrosis Factor—α and Interleukin-1β in Bacterial Vaginosis May Increase Susceptibility to Human Immunodeficiency Virus , 2000 .

[26]  Christopher J. Miller,et al.  Simian Immunodeficiency Virus Rapidly Penetrates the Cervicovaginal Mucosa after Intravaginal Inoculation and Infects Intraepithelial Dendritic Cells , 2000, Journal of Virology.

[27]  P. Watts,et al.  Parameters of Human Immunodeficiency Virus Infection of Human Cervical Tissue and Inhibition by Vaginal Virucides , 2000, Journal of Virology.

[28]  R. Shattock,et al.  In vitro models of mucosal HIV transmission , 2000, Nature Medicine.

[29]  D. Richman,et al.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.

[30]  K. Shimoya,et al.  Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. , 1999, Molecular human reproduction.

[31]  J. Andersson,et al.  Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. , 1998, The American journal of pathology.

[32]  A. Blauvelt,et al.  Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection , 1997, Nature Medicine.

[33]  D. Ho,et al.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.

[34]  E. Holmes,et al.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection , 1993, Journal of virology.

[35]  E. Hafez Structural and ultrastructural parameters of the uterine cervix. , 1982, Obstetrical & gynecological survey.

[36]  P. Elias,et al.  Membrane alterations during cornification of mammalian squamous epithelia: A freeze‐fracture, tracer, and thin‐section study , 1977, The Anatomical record.

[37]  M. Burgos,et al.  Cell junctions in the human vaginal epithelium. , 1970, American journal of obstetrics and gynecology.

[38]  Tapabrata Maiti,et al.  Analysis of Longitudinal Data (2nd ed.) (Book) , 2004 .

[39]  Christopher J. Miller,et al.  Target cells in vaginal HIV transmission. , 2003, Microbes and infection.

[40]  S. Mboup,et al.  High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. , 2000, The Journal of infectious diseases.

[41]  M. Bomsel Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier , 1997, Nature Medicine.

[42]  C. Marchese,et al.  Electron microscopy of human vaginal epithelium under normal and experimental conditions. , 1974, Journal of reproduction and fertility.

[43]  J. Bennett,et al.  The cervix and its secretion in mammals. , 1968, Physiological reviews.